LEXINGTON, Mass. (AP) — LEXINGTON, Mass. (AP) — Voyager Therapeutics Inc. (VYGR) on Tuesday reported a loss of $9 million in its third quarter. On a per-share basis, the Lexington, Massachusetts-based ...

Analysts expect Voyager Therapeutics to report an earnings per share (EPS) of $-0.49. Investors in Voyager Therapeutics are eagerly awaiting the company's announcement, hoping for news of surpassing ...

Voyager Therapeutics (NASDAQ:VYGR – Get Free Report) was downgraded by analysts at StockNews.com from a “buy” rating to a ...

Neurocrine Biosciences, Inc.'s potential for growth in the biopharma sector is strong despite recent setbacks, making its ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Voyager Therapeutics (VYGR – Research Report), Align Tech ...

Allspring Global Investments Holdings LLC cut its holdings in Voyager Therapeutics, Inc. (NASDAQ:VYGR – Free Report) by 66.5% ...

Rhythm Pharmaceuticals, Inc. (RYTM) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended September 2024. This widely-known ...

The market expects Voyager Therapeutics (VYGR) to deliver a year-over-year increase ... but a powerful factor that might influence its near-term stock price is how the actual results compare ...

Semiconductor-sector investors will be paying close attention this week as the major cloud-computing companies report their quarterly results.

The market expects Voyager Therapeutics (VYGR) to deliver a year-over-year increase in earnings ... but a powerful factor that might influence its near-term stock price is how the actual results ...